Evidence map›Paper›PMID 32065337›Full record

ArticleMetabolic brain disease2020

Vanillin and vanillic acid modulate antioxidant defense system via amelioration of metabolic complications linked to Fe

Veronica F Salau, Ochuko L Erukainure, Collins U Ibeji, Tosin A Olasehinde, Neil A Koorbanally, Md Shahidul Islam

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Veronica F SalauDepartment of Biochemistry, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
Ochuko L ErukainureDepartment of Biochemistry, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.ORCID http://orcid.org/0000-0003-0489-338X
Collins U IbejiDepartment of Pure and Industrial Chemistry, Faculty of Physical Sciences, University of Nigeria, Nsukka, 410001, Nigeria.
Tosin A OlasehindeDepartment of Biochemistry and Microbiology, University of Fort Hare, Alice, Eastern Cape, 5700, South Africa.
Neil A KoorbanallySchool of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
Md Shahidul IslamDepartment of Biochemistry, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa. islamd@ukzn.ac.za.
University of KwaZulu-Natal · ZAUniversity of Fort Hare · ZAUniversity of Nigeria · NGUniversity of the Free State · ZAVeritas University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic effect of phenolics on neurodegenerative diseases has been attributed to their potent antioxidant properties. In the present study, the neuroprotective activities of vanillin and vanillic acid were investigated in Fe

Indexed as

Adenosine TriphosphatasesAnimalsAntioxidantsBenzaldehydesCatalaseCell LineCell SurvivalCholinesterase InhibitorsGlutathioneHistidineIronMaleNeurotoxicity SyndromesNitric OxideOxidative StressPentose Phosphate PathwayAdenosine TriphosphatasesAntioxidantsBenzaldehydesCatalaseCholinesterase InhibitorsGlutathioneHistidineIronNitric OxidePurinesVanillic AcidvanillinAntioxidantNeurodegenerationPhenolicsVanillic acidVanillin

Identifiers

PMID32065337
OpenAlexW3006625821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.